Silence Therapeutics plc - ADS (SLN)

Historical Holders from Q3 2020 to Q1 2025

Symbol
SLN on Nasdaq
CUSIP
82686Q101
Type / Class
Equity / ADS
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
24.8M
Holdings value
$168M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
63
Number of buys
35
Number of sells
-32
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Silence Therapeutics plc - ADS (SLN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 322K $907K -$55.4K $2.82 5
2024 Q4 24.8M $168M -$84.8M $6.88 63
2024 Q3 27.6M $490M -$39.9M $18.18 68
2024 Q2 26.6M $497M -$26.6M $19.00 69
2024 Q1 27.7M $588M +$163M $21.60 64
2023 Q4 20.5M $344M +$16.7M $17.37 33
2023 Q3 19.7M $188M +$5.65M $9.82 28
2023 Q2 19.2M $102M +$4.4M $5.50 29
2023 Q1 18.4M $110M -$8.7M $6.20 29
2022 Q4 18.6M $276M +$659K $15.25 27
2022 Q3 18.7M $183M +$89.2M $10.03 29
2022 Q2 10.4M $116M -$33.8M $11.85 24
2022 Q1 12.2M $218M +$34.5M $19.00 25
2021 Q4 10.3M $247M +$171M $23.89 21
2021 Q3 1.96M $39.4M -$5.43M $20.61 7
2021 Q2 2.26M $56.4M -$6.76M $25.78 6
2021 Q1 2.55M $55.9M +$44.9M $23.01 6
2020 Q4 542K $10.2M +$2K $21.51 3
2020 Q3 542K $8.14M +$8.14M $15.50 2